Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127006421 | 12700642 | 1 | I | 201509 | 20151005 | 20160830 | 20160830 | PER | US-SA-2015SA160073 | AVENTIS | 61.00 | YR | A | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127006421 | 12700642 | 1 | PS | MULTAQ | DRONEDARONE | 1 | Oral | Y | UNKNOWN | 22425 | 400 | MG | TABLET | BID | |||||
| 127006421 | 12700642 | 2 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | 200 | MG | ||||||||||
| 127006421 | 12700642 | 3 | C | ATENOLOL. | ATENOLOL | 1 | 0 | 25 | MG | ||||||||||
| 127006421 | 12700642 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127006421 | 12700642 | 1 | Atrial fibrillation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127006421 | 12700642 | Chest discomfort | |
| 127006421 | 12700642 | Condition aggravated | |
| 127006421 | 12700642 | Cough | |
| 127006421 | 12700642 | Feeling abnormal | |
| 127006421 | 12700642 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127006421 | 12700642 | 1 | 20150919 | 20151002 | 0 |